LITERATURE REVIEW: SENSITIVITAS OKSIMETRI NADI DALAM MENGENALI GEJALA PENYAKIT JANTUNG BAWAAN KRITIS

Bilah Samping Artikel

pdf (English)
Diterbitkan: Jun 24, 2024
DOI: https://doi.org/10.34011/jmp2k.v34i2.2011

Isi Artikel Utama

Jundra Darwanty
Politeknik Kesehatan Kemenkes Bandung
Rita Yulifah
Politeknik Kesehatan Kemenkes Malang
Heny Astutik
Politeknik Kesehatan Kemenkes Malang
Ni Wayan Dwi Rosmalawati
Politeknik Kesehatan Kemenkes Malang
Ita Yuliani
Politeknik Kesehatan Kemenkes Malang
Retno Dumilah
Politeknik Kesehatan Kemenkes Malang

Abstrak

Early detection of Critical Congenital Heart Disease (CCHD) in newborns is crucial to the success of treatment. This underlies the need for pulse oximetry screening as the basis for establishing the diagnosis of CCHD that is not recognized on physical examination. This study aimed to analyze the accuracy of pulse oximetry as a CCHD screening method in newborns. The research method was literature review, data is obtained from the PubMed database with the keywords Critical Congenital Heart Disease (CCHD), Newborn, Screening. The inclusion criteria are that the article is published in 2018-2023, discussing the accuracy of pulse oximetry screening, speaking English, and observational analysis research design. Articles according to the criteria were obtained 80 articles. After going through the selection process, 15 articles were selected. An analysis of 15 articles concluded that pulse oximetry has a high accuracy in assisting in the establishment of the diagnosis of CCHD, indicating the need to include it in routine screening procedures for newborns. However, it must be carried out according to regular procedures, by competent health workers, equipped with adequate facilities and it is necessary to educate prospective parents about CCHD screening during pregnancy to anticipate refusal to undergo treatment if abnormalities are found in the results of pulse oximetry.

Rincian Artikel

Cara Mengutip
Darwanty, J., Yulifah, R., Astutik, H., Rosmalawati, N. W. D., Yuliani, I., & Dumilah, R. (2024). LITERATURE REVIEW: SENSITIVITAS OKSIMETRI NADI DALAM MENGENALI GEJALA PENYAKIT JANTUNG BAWAAN KRITIS. Media Penelitian Dan Pengembangan Kesehatan, 34(2), 380-393. https://doi.org/10.34011/jmp2k.v34i2.2011
Terbitan
Vol 34 No 2 (2024): MEDIA PENELITIAN DAN PENGEMBANGAN KESEHATAN
Bagian
Articles

Referensi

F. AlAql, H. Khaleel, and V. Peter, “Universal screening for CCHD in Saudi Arabia: The road to a ‘State of the Art’ program,” Int. J. Neonatal Screen., vol. 6, no. 1, pp. 6–11, 2020, doi: 10.3390/ijns6010013.

P. C. Tsao et al., “Development of a newborn screening program for critical congenital heart disease (CCHD) in Taipei,” PLoS One, vol. 11, no. 4, pp. 1–11, 2016, doi: 10.1371/journal.pone.0153407.

M. J. Campbell, W. O. Quarshie, J. Faerber, D. J. Goldberg, C. E. Mascio, and J. J. Blinder, “Pulse Oximetry Screening Has Not Changed Timing of Diagnosis or Mortality of Critical Congenital Heart Disease,” Pediatr. Cardiol., vol. 41, no. 5, pp. 899–904, 2020, doi: 10.1007/s00246-020-02330-1.

Y. Singh and S. E. Chen, “Impact of pulse oximetry screening to detect congenital heart defects: 5 years’ experience in a UK regional neonatal unit,” Eur. J. Pediatr., vol. 181, no. 2, pp. 813–821, 2022, doi: 10.1007/s00431-021-04275-w.

A. M. Tekleab and Y. C. Sewnet, “

Role of pulse oximetry in detecting critical congenital heart disease among newborns delivered at a high altitude setting in Ethiopia

,” Pediatr. Heal. Med. Ther., vol. 10, pp. 83–88, 2019, doi: 10.2147/phmt.s217987.

S. Al Zarouni et al., “Impact of an electronic medical record-based automated screening program for critical congenital heart disease: Emirates Health Services, United Arab Emirates,” BMC Med. Inform. Decis. Mak., vol. 22, no. 1, pp. 1–7, 2022, doi: 10.1186/s12911-022-01900-y.

M. Khalil, C. Jux, L. Rueblinger, J. Behrje, A. Esmaeili, and D. Schranz, “Acute therapy of newborns with critical congenital heart disease,” Transl. Pediatr., vol. 8, no. 2, pp. 114–126, 2019, doi: 10.21037/tp.2019.04.06.

X. Zhang et al., “The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newborns,” Cardiovasc. Diagn. Ther., vol. 11, no. 2, pp. 447–456, 2021, doi: 10.21037/cdt-20-892.

A. Mukerji et al., “Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis,” Can. J. Public Heal., vol. 111, no. 5, pp. 804–811, 2020, doi: 10.17269/s41997-019-00280-7.

H. Siefkes et al., “Oxygen Saturation and Perfusion Index-Based Enhanced Critical Congenital Heart Disease Screening,” Am. J. Perinatol., vol. 37, no. 2, pp. 158–165, 2020, doi: 10.1055/s-0039-1685445.

M. Kluckow, “Barriers to the implementation of newborn pulse oximetry screening: A different perspective,” Int. J. Neonatal Screen., vol. 4, no. 1, 2018, doi: 10.3390/ijns4010004.

J. S. Kim, M. W. Ariefdjohan, M. K. Sontag, and C. M. Rausch, “Pulse oximetry values in newborns with critical congenital heart disease upon ICU admission at altitude,” Int. J. Neonatal Screen., vol. 4, no. 4, 2018, doi: 10.3390/ijns4040030.

B. Zheleva, S. M. Nair, A. Dobrzycka, and A. Saarinen, “Considerations for newborn screening for critical congenital heart disease in low-and middle-income countries,” Int. J. Neonatal Screen., vol. 6, no. 2, pp. 3–7, 2020, doi: 10.3390/ijns6020049.

H. C. A. Bello et al., “Oximetry and neonatal examination for the detection of critical congenital heart disease: A systematic review and meta-analysis.,” F1000Research, vol. 8, 2019, doi: 10.12688/f1000research.17989.1.

E. Withrow, C. Fussman, K. Thompson, and M. Kleyn, “Evaluation of Pulse Oximetry Screening Rates Among the Midwife-Attended Out-of-Hospital Birth Community in Michigan,” J. Midwifery Women’s Heal., vol. 64, no. 4, pp. 421–426, 2019, doi: 10.1111/jmwh.12958.

G. Sotodate et al., “Comparing risk factors associated with the late detection of critical congenital heart disease at different facility levels,” J. Obstet. Gynaecol. Res., vol. 47, no. 3, pp. 961–967, 2021, doi: 10.1111/jog.14623.

O. Uygur et al., “The value of peripheral perfusion index measurements for early detection of critical cardiac defects,” Pediatr. Neonatol., vol. 60, no. 1, pp. 68–73, 2019, doi: 10.1016/j.pedneo.2018.04.003.

E. Cubells, B. Torres, A. Nuñez-Ramiro, M. Sánchez-Luna, I. Izquierdo, and M. Vento, “Congenital critical heart defect screening in a health area of the community of Valencia (Spain): A prospective observational study,” Int. J. Neonatal Screen., vol. 4, no. 1, 2018, doi: 10.3390/ijns4010003.

I. C. Narayen et al., “Accuracy of Pulse Oximetry Screening for Critical Congenital Heart Defects after Home Birth and Early Postnatal Discharge,” J. Pediatr., vol. 197, pp. 29-35.e1, 2018, doi: 10.1016/j.jpeds.2018.01.039.

L. A. Hom and G. R. Martin, “Newborn critical congenital heart disease screening using pulse oximetry: Value and unique challenges in developing regions,” Int. J. Neonatal Screen., vol. 6, no. 3, pp. 1–5, 2020, doi: 10.3390/IJNS6030074.

B. Han, Y. Tang, X. Qu, C. Deng, X. Wang, and J. Li, “Comparison of the 1-year survival rate in infants with congenital heart disease diagnosed by prenatal and postnatal ultrasound A retrospective study,” Med. (United States), vol. 100, no. 4, pp. 1–11, 2021, doi: 10.1097/MD.0000000000023325.

P. M. Verheijen et al., “Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient,” J. Thorac. Cardiovasc. Surg., vol. 121, no. 4, pp. 798–803, 2001, doi: 10.1067/mtc.2001.112825.

S. C. Papadakis GZ, Millo C, “乳鼠心肌提取 HHS Public Access,” Nature, vol. 456, no. 7223, pp. 814–818, 2008, doi: 10.1016/j.amjcard.2013.11.066.A.

A. T. Cave, S. A. Lowenstein, C. McBride, J. Michaud, E. J. Madriago, and C. Ronai, “Pulse Oximetry Screening and Critical Congenital Heart Disease in the State of Oregon,” Clin. Pediatr. (Phila)., vol. 60, no. 6–7, pp. 290–297, 2021, doi: 10.1177/00099228211008704.

C. L. Diller, M. S. Kelleman, K. G. Kupke, S. C. Quary, L. K. Kochilas, and M. E. Oster, “A modified algorithm for critical congenital heart disease screening using pulse oximetry,” Pediatrics, vol. 141, no. 5, 2018, doi: 10.1542/peds.2017-4065.

W. T. Mahle et al., “Role of pulse oximetry in examining newborns for congenital heart disease: A scientific statement from the American Heart Association and American Academy of Pediatrics,” Circulation, vol. 120, no. 5, pp. 447–458, 2009, doi: 10.1161/CIRCULATIONAHA.109.192576.

N. El Idrissi Slitine et al., “Pulse oximetry and congenital heart disease screening: Results of the first pilot study in Morocco,” Int. J. Neonatal Screen., vol. 6, no. 3, pp. 1–7, 2020, doi: 10.3390/IJNS6030053.

D. Jain, M. Jain, and Y. Lamture, “Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates,” Cureus, vol. 14, no. 12, pp. 12–19, 2022, doi: 10.7759/cureus.32852.

I. K. Murni et al., “Feasibility of screening for critical congenital heart disease using pulse oximetry in Indonesia,” BMC Pediatr., pp. 4–11, 2022, doi: 10.1186/s12887-022-03404-0.

D. Dilli et al., “Should we start a nationwide screening program for critical congenital heart disease in Turkey? A pilot study on four centres with different altitudes,” Cardiol. Young, vol. 29, no. 4, pp. 475–480, 2019, doi: 10.1017/S1047951119000052.

A. Henderson, D. Aguirre, A. Singh, and A. K. Ewer, “Temporal trends in routine predischarge pulse oximetry screening: 6 years experience in a UK regional neonatal unit,” Arch. Dis. Child. Fetal Neonatal Ed., vol. 107, no. 3, pp. F256–F261, 2022, doi: 10.1136/archdischild-2021-322303.

G. R. Martin et al., “Updated strategies for pulse oximetry screening for critical congenital heart disease,” Pediatrics, vol. 146, no. 1, 2020, doi: 10.1542/peds.2019-1650.

S. Thangaratinam, K. Brown, J. Zamora, K. S. Khan, and A. K. Ewer, “Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: A systematic review and meta-analysis,” Lancet, vol. 379, no. 9835, pp. 2459–2464, 2012, doi: 10.1016/S0140-6736(12)60107-X.

L. A. Hom, C. Chan Salcedo, M. Revenis, and G. R. Martin, “Quality Improvement Interventions to Improve Critical Congenital Heart Disease Screening,” Pediatr. Qual. Saf., vol. 4, no. 5, p. E221, 2019, doi: 10.1097/pq9.0000000000000221.

A. M. van Niekerk, R. M. Cullis, L. L. Linley, and L. Zühlke, “Feasibility of pulse oximetry pre-discharge screening implementation for detecting critical congenital heart lesions in newborns in a secondary-level maternity hospital in the Western Cape, South Africa: The ‘POPSICLe’ study,” South African Med. J., vol. 106, no. 8, pp. 817–821, 2016, doi: 10.7196/SAMJ.2016.v106i8.10071.

Q. M. Zhao et al., “Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: A prospective study,” Lancet, vol. 384, no. 9945, pp. 747–754, 2014, doi: 10.1016/S0140-6736(14)60198-7.

X. J. Hu et al., “Pulse oximetry and auscultation for congenital heart disease detection,” Pediatrics, vol. 140, no. 4, 2017, doi: 10.1542/peds.2017-1154.